Molecular neurobiology investigates the biological mechanisms that are responsible for the emergence and processing of neuronal communication. It is an interdisciplinary science which combines the principles of genetics, molecular biology, and biochemistry with neuroscience. Molecular neurobiologists explore the cellular and molecular composition of neurons, glial cells, and other cell types that make up the brain. Through examining these components, scientists uncover the biological basis of things such as behavior, sensation, learning, and memory. A major focus of molecular neurobiology is understanding the interactions between neurons and their specialized scaffold proteins. Through studying these interactions, researchers can gain a better understanding of neuronal communication and how it is affected by various diseases and conditions. They identify how particular proteins play their role in pattern recognition, neuromodulation, and synaptic plasticity. Molecular neurobiologists also investigate the molecular basis of neural development and connectivity. They look for the processes that control neuronal development and how gene expression affects neural networks. Additionally, they study how environmental conditions and lifestyle choices can alter gene expression and cause neurological disorders. By learning the molecular components of the nervous system, we can develop treatments and therapies for diseases such as Alzheimer’s, Parkinson’s, and autism. Molecular neurobiology is a key to understanding the brain’s complexity and can help us unlock its secrets.
Title : Atypical presentation of Juvenile myoclonic epilepsy in a 16-year-old female: A case report
George Diaz, Memorial Healthcare Systems, United States
Title : Triple-network dysfunction, ME/CFS, and the NeuroPhysics Treatment Process “A dynamical systems perspective on psychophysical organization and environmental interaction”
Ken Ware, NeuroPhysics Therapy Institute and Research Centre, Australia
Title : Beyond plaques: 10-nanometer-scale pathoconnectomics of Alzheimer’s disease
Ons M Saad, Panluminate Inc., United States
Title : Results from the global phase 3 trial (IB1001-303) evaluating levacetylleucine in children and adults with ataxia-telangiectasia
Chidinma Ejim, IntraBio, United States
Title : A phase 3, multinational, randomized, placebo-controlled, double-blind, crossover trial (IB1001-304) evaluating levacetylleucine in CACNA1A
Chidinma Ejim, IntraBio, United States
Title : Clinical and molecular phenotype of PTRHD1-associated juvenile parkinsonism
Bhavan A Modi, Barrow Neurological Institute at Phoenix Children's, United States